Federal award (PURCHASE ORDER, fiscal year 2024)
Recipient: REVVITY HEALTH SCIENCES, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2025-04-11 to 2026-04-06
Current total value of award: $12440.16
Description: HTRF MAB ANTI 6HIS-TB AND STREPTAVIDIN-XLENT - 20K PTS